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Abstract
Background: Clinical data on myocardial function in HCM mutation carriers (carriers) is sparse but suggests that
subtle functional abnormalities can be measured with tissue Doppler imaging before the development of overt
hypertrophy. We aimed to confirm the presence of functional abnormalities using cardiovascular magnetic
resonance (CMR), and to investigate if sensitive functional assessment could be employed to identify carriers.
Results: 28 carriers and 28 controls were studied. Global left atrial (LA) and left ventricular (LV) dimensions,
segmental peak systolic circumferential strain (SCS) and peak diastolic circumferential strain rate (DCSR), as well as
the presence of late Gadolinium enhancement (LGE) were determined with CMR. Septal and lateral myocardial
velocities were measured with echocardiographic tissue Doppler imaging. lv mass and volumes were comparable
between groups. Maximal septal to lateral wall thickness ratio (SL ratio) was larger in carriers than in controls (1.3 ±
0.2 versus 1.1 ± 0.1, p < 0.001). Also, LA volumes were larger in carriers compared to controls (p < 0.05). Both peak
SCS (p < 0.05) and peak DCSR (p < 0.01) were lower in carriers compared to controls, particularly in the basal
lateral wall. Focal LGE was present in 2 carriers and not in controls. The combination of a SL ratio >1.2 and a peak
DCSR <105%.s
-1 was present in 45% of carriers and in none of the controls, yielding a positive predictive value of
100%. Two carriers and 18 controls had a SL ratio < 1.2 and peak DCSR >105%.s
-1, yielding a negative predictive
value of 90%. With multivariate analysis, HCM mutation carriership was an independent determinant of reduced
peak SCS and peak DCSR.
Conclusions: HCM mutation carriership is an independent determinant of reduced peak SCS and peak DCSR when
LV wall thickness is within normal limits, and is associated with increased LA volumes and SL ratio. Using SL ratio
and peak DCSR has a high accuracy to identify carriers. However, since carriers also display structural abnormalities
and focal LGE, we advocate to also evaluate morphology and presence of LGE when screening for carriers.
Background
Hypertrophic cardiomyopathy (HCM) is a relatively
common cardiomyopathy with an estimated prevalence
of 1:500 in the general population [1]. The clinical
course has a large inter- and intrafamilial heterogeneity,
ranging from mild symptoms of heart failure late in life
to the onset of sudden cardiac death at young age. Over
430 mutations in mainly sarcomeric genes have been
identified to cause HCM. It has been suggested that the
hypertrophy in HCM is a compensatory mechanism for
mutant-induced myocardial dysfunction [2-4]. This
hypothesis is supported by experimental data demon-
strating that sarcomeric dysfunction precedes hypertro-
phy in HCM animal models [5-7].
Limited clinical data is available on regional myocar-
dial function in human HCM mutation carriers (car-
riers) when wall thickness is still within normal limits.
Several studies using tissue Doppler imaging with
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stolic myocardial velocities were reduced prior to the
development of manifest hypertrophy [8,9]. However,
evaluation of myocardial function with tissue Doppler
imaging was not accurate enough to rule out HCM
mutation carriership [8-10].
The high spatial and temporal resolution of cardiovas-
cular magnetic resonance (CMR) and its well developed
capabilities to assess morphology and intramural myo-
cardial deformation, are of specific interest to evaluate
the regional function of human carriers with normal
wall thickness [11,12].
In this study, we investigate whether segmental systo-
lic and diastolic myocardial dysfunction is detectable
with CMR and can be used to identify carriership in
carriers with normal left ventricular (LV) wall thickness
when compared to controls.
Methods
Patient selection
Carriers were included in whom LV wall thickness was
less than 10 mm measured by routine echocardiography
w i t h i no n ey e a rb e f o r ee n t e r i n gt h es t u d y[ 1 2 ] .A l lc a r -
riers were free of any other systemic or cardiac disease,
which might attribute to the development of LV
hypertrophy.
As a control group, age and gender matched non-
smoking healthy volunteers were selected who had no
medical history, no known familial cardiac disease, no
obesity and normal blood pressure. Family members of
the carriers without the pathogenic mutation, who met
the inclusion criteria of healthy volunteers, were also
included. Study participants had to be in sinus rhythm,
and free from standard exclusion criteria for CMR. In
all participants, standard physical examination, CMR
and echocardiography were performed.
The study was approved by the institutional medical
ethics committee and conducted according to the
declaration of Helsinki. Written informed consent was
obtained from all participants before entering the study.
Cardiovascular Magnetic Resonance
CMR was performed on a 1.5-Tesla whole body scanner
(Magnetom Sonata, Siemens, Erlangen, Germany), using
as i x - c h a n n e lp h a s e d - a r r a yb o d yc o i l .A l lc i n es t u d i e s
were acquired in a single breath hold of 8-10 seconds
during mild expiration.
Cine imaging
After survey scans, a retro-triggered, balanced, steady-
state free precession gradient-echo sequence was used
for cine imaging. A cine dataset fully covering the left
atrium (LA) and LV was acquired as described pre-
viously [13]. Image parameters were: slice thickness 5
mm, slice gap 5 mm, temporal resolution <50 ms,
repetition time 3.2 ms, echo time 1.54 ms, flip angle 60
degrees and a typical in-plane image resolution of 1.3 by
1.6 mm. The number of phases within the cardiac cycle
was set at 20. A high temporal resolution (14 ms) 3-
chamber cine was obtained to determine opening and
closure times of aortic and mitral valves. Brachial blood
pressure was non-invasively measured directly after
acquisition of the high temporal resolution 3-chamber
cine.
Myocardial tissue tagging
A multiple breath-hold, retrospective triggered balanced
steady state free precession myocardial sinus tagging
sequence was obtained using the linearly increasing
start-up angle approach [11]. Three LV short axis planes
were positioned at 25 percent, 50 percent and 75 per-
cent of the distance between the mitral valve annulus
and the endocardial border of the apex on an end-systo-
lic LV 4-chamber view, avoiding inclusion of the LV
outflow tract. Imaging time per slice was approximately
3-4 minutes. Image parameters were: 7 mm slice thick-
ness, temporal resolution 14.1 ms, repetition time 4.7
ms, echo time 2.3 ms, flip angle 20 degrees, and in-
plane image resolution of 1.2 by 3.8 mm, with 7 mm tag
spacing.
Late gadolinium enhancement imaging
Late gadolinium enhancement (LGE) images were
obtained 10-15 minutes after injection of 0.2 mmol·kg
-1
gadolinium-dtpa [14]. A single breath-hold, inversion
recovery turbo Fast Low Angle Shot sequence was used.
All LGE images were ecg-gated to end-diastole and
planned at the same image positions as the long and
short axis LV cines. Image parameters were: 5 mm slice
thickness, repetition time 4.0 ms, echo time 4.4 ms, flip
angle 25 degrees and typical in-plane image resolution
1.3 by 1.3 mm. Typical inversion recovery time was 250
to 300 ms.
Post processing
Cine images where analyzed off-line, using MASS analy-
sis software (Medis medical imaging systems, Leiden,
The Netherlands) blinded for genotypes. From the LA
cine dataset, LA volumes were calculated from manually
drawn endocardial contours in every phase of the car-
diac cycle, excluding the pulmonary veins and including
the LA appendage, as described previously [13]. LA
maximum volume, LA minimum volume, LA volume at
diastasis and LA volume prior to atrial contraction were
determined. From these volumes, LA reservoir volume,
LA passive emptying volume, LA active emptying
volume and LA ejection function were calculated as
described previously [13].
O nt h eL Vc i n ed a t as e t ,e p i -a n de n d o c a r d i a lc o n -
tours were manually drawn in end-diastole and end-sys-
tole. Global LV parameters, including LV end-diastolic
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LV ejection fraction (lvef) and LV mass were deter-
mined. Also, LV mass to LV volume ratio in end-dia-
stole was determined [13]. All volumes and mass were
normalized to body surface area. Isovolumetric relaxa-
tion time (ivrt) was calculated by subtracting aortic
valve closure time from mitral valve opening time,
determined on the high temporal resolution 3-chamber
view.
For segmental analysis, the basal, mid and apical LV
cine slices best corresponding with the myocardial tissue
tagging slices were selected. These three slices were sub-
divided into 16 segments - excluding the apex- accord-
ing to the standardized myocardial segmentation for
tomographic imaging of the heart [15]. Per LV segment,
mean ED wall thickness and mean end-systolic wall
thickness were measured. Wall thickening was calcu-
lated by dividing (end-systolic wall thickness - ED wall
thickness) by ED wall thickness. In addition, maximal
septal-to-lateral wall thickness ratio (SL ratio) was calcu-
lated by dividing maximal ED wall thickness of the sep-
tum by maximal lateral ED wall thickness, and ED wall
radius was defined as the mean radial distance for the
centre point of the LV slice to the endocardial border.
This was semi-automatically calculated using MASS
software.
Offline analysis of the myocardial tissue tagging
images was performed with in-house developed soft-
ware, programmed in a matlab 7.1(R14) environment
(The MathWorks, Natick, Massachusetts, United States
of America), as described previously [11]. Segmental cir-
cumferential strain was calculated from Lagrangian
strain as a percent change in length of a small line seg-
ment in the circumferential direction. Since myocardial
fibers of the mid LV wall are predominantly oriented
circumferentially and lie within the short axis image
plane, circumferential strain was calculated only from
the mid 50 percent of the LV wall [16].
From these segmental circumferential strain datasets,
the following parameters were determined: peak systolic
circumferential strain (peak SCS) and peak diastolic cir-
cumferential strain rate (peak DCSR).
Echocardiography
Echocardiography was performed using a General Elec-
tric Vivid-7 (GE Vingmed Ultrasound, Horten, Norway)
ultrasound system. Echopac (GE, Horten, Norway) was
used for offline analysis of recordings. Values of pre-
sented parameters are the means of 3 recorded mea-
surements per parameter. The echocardiogram was
performed immediately before or after the CMR study
to minimize the effect of differences in physiological
conditions of the participants between echocardio-
graphic and CMR measurements.
Colour tissue Doppler imaging was performed on an
apical 4-chamber view using a 2.5-MHz transducer and
frame rates over 80/second. Systolic, early diastolic and
late diastolic peak myocardial velocities of the septal and
lateral mitral valve annulus corner were obtained by pla-
cing a 6-mm sample volume at the junction of the
mitral annulus at septal and lateral myocardial wall. The
angle of incidence between the scan lines and motion of
the base of the heart was minimized.
Statistical Analysis
All data are presented as mean ± standard deviation.
The unpaired Student’s t-test was used for comparison
of normally distributed global LV and LA parameters
between carriers and controls or a non-parametric
Mann-Whitney U test when appropriate.
For segmental analysis, ED wall thickness, wall thick-
ening, peak SCS and peak DCSR were compared
between carriers and controls. While interdependency of
segments was considered within slices and patients,
multilevel analysis allowing random intercepts was per-
formed. With multiple regression analysis, the effect of
HCM carriership, age, gender, ED wall thickness and
ED wall radius on wall thickening, peak SCS and peak
DCSR was evaluated, correcting for interdependency of
segments. Pearson’s correlation coefficient was used to
describe bivariate correlations between continuous vari-
ables. All regression models were evaluated for interac-
tion of main effects. Evaluation of within slice
differences of segmental parameters was performed with
a one-way anova, using the Bonferroni post-hoc test for
multiple comparisons. The Bland-Altman method for
agreement analysis was used to evaluate the intra- and
interobserver agreement of the strain data [17]. Also,
the coefficient of variability was calculated by dividing
the standard deviation of two measurements by their
mean, as described previously [18]. mlwin 2.02 (Center
of MultiLevel Modelling (Bristol, United Kingdom) was
used for multilevel analysis and Statistical Package of
Social Sciences (spss for windows 14.0, Chicago, Illinois,
United States of America) for all other statistical analy-
sis. We used receiver operator characteristics to gener-
ate cut-off values to optimize sensitivity and specificity
to distinguish carriers from controls. Comparison
between ROC curves was performed according to the
method described by Hanley and McNeil using Analyse-
it Clinical Laboratory 2.12 (Analyse-It Software, Ltd.)
[19]. A two-sided p-value at the < 0.05 level was consid-
ered statistically significant.
Results
In total, 28 carriers (11 males) from nine different
families were included, of whom 22 (79%) had a myosin
binding protein C3 founder mutation (MYBPC3)
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(Glu62Gln) [20,21]. Fifteen of the 28 age- and gender-
matched controls were confirmed genotype negative
family members of the carriers. All global LV and LA
data and regional LV data were comparable between
genotype negative controls and selected healthy volun-
teers. Systolic and diastolic blood pressures were lower
in carriers compared to controls but within normal lim-
its, see table 1. In total, data from 896 segments were
obtained. All segmental data from the cine images were
analyzable. Segmental strain data from 408 out of 448
(91.1%) segments could be used for analysis in carriers,
and from 375 out of 448 (83.7%) in controls. The
remaining segments were not analyzable due to incon-
sistency of repetitive breath holding. Tissue Doppler
echocardiography was performed in 15 carriers and 12
controls.
Global LA and LV volumes and function
Both LA minimum and LA maximum volume were lar-
ger in carriers compared to controls (p < 0.05) but LA
passive emptying and LA active emptying were compar-
able, see table 2. No differences in global LV volumes,
mass and isovolumetric relaxation time were found
between both groups. In contrast, SL ratio was larger in
carriers compared to controls (p < 0.001). LGE was
observed in two MYBPC3 carriers (7%) and not in con-
trols. Interestingly, the pattern of LGE was patchy and
located typically at both insertion areas of the right ven-
tricle into the non- hypertrophied septum, see figure 1.
Segmental analysis
All data per segment are presented in Additional file 1.
The analysis of strain data had a high level of intra- and
interobserver agreement for all strain parameters with a
variability ranging from 1% for peak SCS, to 9% for peak
DCSR, see table 3.
End diastolic wall thickness
Averaged ED wall thickness was comparable between
carriers and controls (5.9 ± 0.9 mm versus 5.1 ± 0.9
mm in the basal slice, 4.9 ± 0.9 mm versus 4.7 ± 0.8
mm in the mid slice and 3.9 ± 1.0 mm versus 3.7 ± 0.8
mm in the apical slice, p = 0.23). In both septal seg-
ments of the basal slices, ED wall thickness was larger
in carriers compared to controls (7.3 ± 1.5 mm versus
6.1 ± 1.4 mm, p < 0.01 for the inferoseptal segments
and 6.4 ± 1.0 mm versus 5.7 ± 1.3 mm, p < 0.05 for the
anteroseptal segments), see figure 2a. In all other seg-
ments, ED wall thickness was comparable (mean 4.9 ±
0.8 mm versus 5.0 ± 1.3 mm, p = 0.18).
Wall thickening
In both basal septal segments, wall thickening was lower in
carriers compared to controls (0.39 ± 0.21 versus 0.65 ±
0.23, p < 0.001 for the inferoseptal segment and 0.61 ±
0.31 versus 0.84 ± 0.28, p < 0.01 for the anteroseptal seg-
ment). In the lateral segments, wall thickening was com-
parable between groups, see figure 2b.
Peak systolic circumferential strain
No significant differences in averaged peak SCS were
observed between carriers and controls. Peak SCS was
lower only in the basal inferolateral segment in HCM
carriers compared to controls (-17.8 ± 3.3% versus -19.9
± 3.5%, p < 0.05), see figure 2c. Interestingly, peak SCS
was comparable between septal and lateral segments in
carriers, but not in controls (p < 0.001), see figure 2c.
Multilevel regression analysis showed that HCM
mutation carriership, (b = 0.66 ± 0.26, p < 0.001 indicat-
ing lower peak SCS in carriers), gender (b = -0.86 ±
0.26, p < 0.001 indicating larger peak SCS in females
compared to males) and ED wall thickness (b =0 . 3 9±
0.10, p < 0.01) were all independent predictors of peak
SCS. There was no interaction of main effects. The
effect of ED wall radius on peak SCS was significantly
Table 1 Baseline characteristics
Carriers (n = 28) Controls (n = 28)
Age (years) 38 ± 13.2 39 ± 12.3
Gender (male/female) 11/17 11/17
systolic BP (mmHg) 115 ± 12 124 ± 12*
Diastolic BP (mmHg) 66 ± 10 72 ± 7*
Heart rate (beats per minute) 63 ± 9 67 ± 9
Body mass index (kg·m
-2) 22.9 ± 2.6 22.7 ± 2.6
Data are presented as mean ± S.D. BP = blood pressure, carriers =
hypertrophic cardiomyopathy mutation carriers. * = p < 0.05
Table 2 Left ventricular and left atrial volumes and
function
Carriers (n = 28) Controls (n = 28)
LA min (mL.m
-2) 24 ± 6.7 20 ± 3.9*
LA max (mL.m
-2) 56 ± 11.7 51 ± 6.4*
LA PE (mL.m
-2) 19 ± 4.6 18 ± 5.0
LA AE (mL.m
-2) 14 ± 4.8 13 ± 3.1
LAEF (%) 35 ± 8.0 38 ± 7.2
LVEDV (mL.m
-2) 96 ± 13.2 94 ± 14.2
LVESV (mL.m
-2) 38 ± 7.3 37 ± 8.3
SV (mL.m
-2) 58 ± 8.9 57 ± 7.7
LVEF (%) 60 ± 4.9 61 ± 4.2
LV mass (gr.m
-2) 99 ± 24.2 93 ± 22.9
LV mass/volume ratio 0.53 ± 0.075 0.54 ± 0.105
IVRT (ms) 102 ± 18 100 ± 22
SL ratio 1.3 ± 0.21 1.1 ± 0.13
‡
Data are presented as mean ± S.D. All volumes are indexed to body surface
area, AE = active emptying, EDV = end diastolic volume, ESV = end systolic
volume, IVRT = isovolumetric relaxation time, LA = left atrial, LAEF = left atrial
ejection function, LV = left ventricular, LVEF = left ventricular ejection fraction,
max = maximum volume, min = minimum volume, PE = passive emptying. SL
ratio = septal to lateral wall thickness ratio, SV = stroke volume. * = p < 0.05,
‡ = p < 0.001
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regression coefficients b were -0.19 ± 0.03 (p < 0.001)
and -0.11 ± 0.04 (p < 0.01) respectively, indicating that
an increase in ED wall radius was related to larger peak
SCS. This effect was stronger in controls compared to
carriers (p < 0.05).
Peak diastolic circumferential strain rate
Averaged peak DCSR was lower in all slices in carriers,
especially in the basal slice (98 ± 18%·s
-1 versus 115 ±
17%·s
-1, p < 0.001). In addition, the difference in peak
DCSR between carriers and controls was largest in the
basal lateral segments (95 ± 23%·s
-1 versus 130 ± 30%·s
-1,
p < 0.001 in the anterolateral segment and 116 ± 36%·s
-1
versus 139 ± 26%·s
-1, p < 0.05 in the inferolateral seg-
ment), see figure 2d. In both carriers and controls, peak
DCSR was highest in the inferolateral segments com-
pared to the other segments (p < 0.01).
With multilevel regression analysis, HCM mutation
carriership, (b = -9.0 ± 2.26; p < 0.001), gender (b =
11.4 ± 2.4; p < 0.001) and ED wall thickness (b =- 3 . 5±
0.9; p < 0.001) were all independent determinants of
p e a kD C S R .A g a i n ,E Dw a l lr a d i u sw a sa ni n d e p e n d e n t
determinant of peak DCSR in controls (p < 0.001), but
not in carriers.
The effect of ED wall thickness on regional function
The effect of ED wall thickness on segmental functional
parameters is illustrated in figure 3. Mean peak DCSR was
significantly lower in carriers when ED wall thickness was
≥ 6 mm and further decreased with increase of ED wall
thickness. Peak SCS only tended to be lower in carriers
than in controls when ED wall thickness was >10 mm
(-15.6 ± 3.5% versus -17.6 ± 1.6%, p = 0.05).
Septal and lateral systolic, early diastolic and late dia-
stolic velocities assessed with tissue Doppler imaging
were comparable between both groups in our study
population, see table 4.
Identification of carriers
Receiver operator characteristics analysis identified both
SL ratio and peak DCSR of the lateral wall of the basal
segment as valuable parameters to discriminate carriers
from controls. Area under curve of SL ratio and basal
inferolateral peak DCSR were comparable (0.72 ± 0.07,
p < 0.001 and 0.69 ± 0.08, p = 0.02). Using an optimal cut-
off value of 1.2 for SL ratio yielded a sensitivity, specificity,
positive and negative predictive value of 75%, 88%, 81%
and 77% respectively. An optimal cut-off value of 105%.s
-1
Figure 1 LGE displaying a typical pattern of enhancement in a myosin binding protein C3 mutation carrier with normal LV wall
thickness. A. Midventricular LV short axis orientation on which enhancement is visible at the superior and inferior insertion point of the right
ventricle into the septum (white arrowheads). These areas often typically display enhancement in manifest HCM patients. Image 1B was planned
perpendicular to the inferior area of enhancement as indicated by the dashed line. B. Modified 2 chamber LGE image through the inferoseptum.
The area of enhancement is indicated by the white arrowheads and is located in the midwall of the inferoseptum, extending towards the apex.
* = anterolateral papillary muscle, LA = left atrium, LV = left ventricle, RV = right ventricle
Table 3 Intra- and interobserver variability of strain
parameters obtained with myocardial tissue tagging.
intraobserver variability interobserver variability
mean
difference
± S.D.
coefficient of
variation
mean
difference
± S.D.
coefficient of
variation
peak SCS
(%)
0.03 ± 0.25 0.02 0.16 ± 1.3 0.01
peak DCSR
(%·s
-1)
0.02 ± 0.3 0.01 0.04 ± 9.5 0.09
S.D. = standard deviation, DCSR = diastolic circumferential strain rate, SCS =
systolic circumferential strain
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Page 5 of 10Figure 2 Segmental comparison of basal left ventricular segments between carriers and controls. Data are presented as mean ± standard
error of the mean as indicated by the solid bars (carriers) and open bars (controls). A. EDWT was higher in the septal and inferior segments in
carriers compared to controls. Also the asymmetric, predominantly septal distribution of increased wall thickness was observed in the carriers. B.
Wall thickening was lower in the septum in carriers compared to controls. C. In controls, peak SCS was higher in the lateral wall compared to
the septum, but this difference was less overt in carriers. As a result, peak SCS was significantly larger in the lateral segments of controls
compared to carriers. D. Peak diastolic circumferential strain rate is reduced in almost every segment in carriers compared to controls. Again, the
heterogeneity in peak DCSR found in controls was less profound in carriers. IS = inferoseptal, AS = anteroseptal, AN = anterior, AL =
anterolateral, IL = inferolateral, IN = inferior, EDWT = end diastolic wall thickness, peak DCSR = peak diastolic circumferential strain rate, peak
SCS = peak systolic circumferential strain. * = p < 0.05,
† = p < 0.01,
‡ = p < 0.001
Figure 3 Relation between functional parameters and different categories of EDWT. Note that both peak SCS (A) and peak DCSR (B) tend
to decrease with an increase in wall thickness in carriers (solid dots), but not in controls (open dots). EDWT = end diastolic wall thickness, peak
DCSR = peak diastolic circumferential strain rate, peak SCS = peak systolic circumferential strain. * = p < 0.05,
† = p < 0.01,
‡ = p < 0.001
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specificity, positive and negative predictive value was 58%,
80%, 73% and 65% respectively. As presented in figure 4,
only 2 carriers (8%) had both an SL ratio <1.2 ánd a peak
DCSR in the lateral wall >105%.s
-1 versus 18 (72%) of con-
trols, p < 0.001, yielding a negative predictive value of
90%. Seven carriers (28%) had a SL ratio >1.2 and peak
DCSR >105%.s
-1 versus 3 controls (7%, p < 0.01). In addi-
tion, 11 carriers (45 percent) had a SL ratio >1.2 ánd a
peak DCSR <105%.s
-1 versus none of the controls, p <
0.001, yielding a positive predictive value of 100%. Thus,
combining both functional and morphological parameters
increases the accuracy to identify carriers, but does not
completely exclude HCM mutation carriership.
Discussion
This is the first study that used CMR to assess global
LA and LV volumes and regional intramural myocardial
function in carriers with normal wall thickness. The
asymmetry in wall thickness between the septum and
lateral wall, which is characteristic for HCM, was
already present in these carriers with normal wall thick-
ness. Typical focal LGE was present in 2 carriers. Also,
LA volumes were larger in carriers. In addition, HCM
mutation carriership was identified as an independent
determinant of reduced peak SCS and peak DCSR,
which was predominantly present in the basal lateral
segments. Peak DCSR further deteriorated with increase
in wall thickness. Using both the SL ratio and peak
DCSR for identification of carriers had a high accuracy
to identify carriers, but did not completely exclude
HCM mutation carriership.
The finding of myocardial dysfunction in carriers with
normal wall thickness supports the hypothesis that the
hypertrophy in HCM represents a compensatory
mechanism in response to abnormal intrinsic myocardial
mechanical properties, as has been stated previously
[2,8,9]. In a study performed by Ho and co-workers,
who used tissue Doppler imaging to measure myocardial
function in carriers with normal wall thickness, early
diastolic velocities were found to be lower in carriers
compared to controls in all corners of the mitral valve
annulus [9]. This is in line with the findings in this
study. However, myocardial velocities in that study were
higher compared to this population, which might result
from the younger age in their population (24.2 ± 10
years in the study of Ho and co-workers versus 38 ± 13
years in this study) [9]. The younger age and higher
early diastolic velocities might also explain why, in con-
trast to our findings, LA volumes were not enlarged.
Moreover, Ho and co-workers found that LVEF was sig-
nificantly higher in carriers. This may again be an age-
related effect, but may also be caused by differences in
the measurement method of LVEF, since with echocar-
diography, papillary muscles are excluded from the LV
mass, while we included the papillary muscles in the LV
mass according to standardized CMR methods [22].
A study performed by Nagueh and co-workers, who
also measured myocardial function with tissue Doppler
imaging in a small cohort of HCM mutation carriers,
found that both systolic and diastolic myocardial veloci-
ties were reduced [9]. However, wall thickness was
higher in their study and most HCM mutation carriers
in their population subsequently developed HCM within
two years after inclusion into the study [23].
Therefore, diastolic dysfunction seems to be the ear-
liest clinically detectable functional alteration as a result
of the mutation. This is in line with experimental data
on functioning of mutated sarcomeric proteins in a
HCM model, which demonstrate that as a result of the
HCM mutation, Ca
2+ sensitivity of the myofilaments is
increased, thereby enhancing initial contractility but
Table 4 Tissue Doppler Imaging parameters of HCM
mutation carriers and controls
Carriers (n = 16) Controls (n = 12)
septal Sa (cm·s
-1) 8.7 ± 1.4 9.5 ± 2.4
Ea (cm·s
-1) 9.5 ± 3.2 9.5 ± 2.7
Aa (cm·s
-1) 8.0 ± 1.4 9.2 ± 2.2
lateral Sa (cm·s
-1) 10.8 ± 3.3 12.3 ± 2.5
Ea (cm·s
-1) 13.0 ± 4.5 12.7 ± 3.4
Aa (cm·s
-1) 9.0 ± 2.1 10.3 ± 2.6
Data are presented as mean ± standard deviation. Aa = late diastolic
myocardial velocity at the level of the mitral valve annulus, Ea = early diastolic
myocardial velocity at the level of the mitral valve annulus, Sa = systolic
myocardial velocity at the level of the mitral valve annulus.
Figure 4 Combining the evaluation of SL ratio and peak DCSR
in the basal inferolateral segment from the identification of
carriers. Optimal cut-off was >1.2 and < 105%·s
-1 to positively
identify carriers (solid bars). Note that only 2/25 (8%) of carriers did
not meet neither this criteria, and no controls (open bars) met both
criteria. Peak DCSR = peak diastolic circumferential strain rate, SL
ratio = septal to lateral wall ratio.
† = p < 0.01,
‡ = p < 0.001.
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of all 16 segments, we found that reduced diastolic func-
tion in carriers was mainly caused by reduced peak
DCSR in the basal segments of the myocardium and
were most profound in the lateral segments.
In previous observations, we found in that peak SCS
was largest in the inferolateral segments of the LV in
healthy volunteers [11]. In this study, we found that ED
wall radius was largest in the inferoseptal segments.
Indeed, ED wall radius was found to be an independent
determinant of peak SCS and peak DCSR in controls,
suggesting a Frank-Straling mechanism. However, this
relation was not found in HCM mutation carriers. This
would explain why differences in peak SCS and peak
DCSR found between controls and HCM mutation car-
riers were most profound in the inferolateral wall. Indeed
an impaired response to preload in mutated sarcomeres
has also been suggested in experimental studies [24].
However, this needs to be confirmed in further studies.
The reduction of regional peak DCSR was further
enhanced with increase in ED wall thickness. It is unli-
kely that replacement fibrosis plays an important role in
the deterioration of diastolic function in carriers with
increase of ED wall thickness. However, diffuse intersti-
tial fibrosis and/or myocyte disarray cannot be visualized
with LGE imaging, so the attribution of these histologi-
cal hallmarks of HCM on the development of diastolic
dysfunction still needs to be further investigated. New
promising CMR techniques have been developed that
allow quantification of diffuse interstitial fibrosis. This
would enable us to quantify the total fibrotic burden of
the LV in HCM patients [27]. In this study, two
MYBPC3 carriers demonstrated LGE, and the pattern of
enhancement was typical for HCM, being located at the
insertion sites of the right ventricle into the septum.
LGE in carriers likely represents early myocardial
damage that results from either micro infarction as a
result of intramural coronary arteriopathy - which is
often found in HCM - or concomitant myocardial
inflammation [28]. Whether LGE in carriers heralds
propagation to manifest HCM, or indicates an increased
risk for ventricular arrhythmias needs to be clarified in
future research.
Clinical implications
Since HCM is relatively uncommon with an estimated
prevalence in general population of 1:500, screening for
carriers is only efficient in first degree, asymptomatic
family members of HCM patients, who have a 50 per-
cent pre-test likelihood of disease. In this preselected
population, the presence of both a SL ratio >1.2 and a
peak DCSR in the lateral segments <105%.s
-1 had a posi-
tive predictive value of 100% for carriership. Having a
SL ratio <1.2 and a peak DCSR >105%.s
-1 had a negative
predictive value of 90 percent. Therefore, functional
abnormalities alone are not specific enough to be used
to exclude HCM mutation carriership when screening
asymptomatic family members of HCM patients in
whom no mutation has yet been identified.
Since structural abnormalities, as well as focal areas of
LGE have also been described in carriers with normal
wall thickness, we advocate to also include evaluation of
morphology and presence of LGE when screening for
carriers to increase the accuracy of screening [12,29,30].
In addition, these findings might help to estimate the
risk of carriers to develop HCM and/or arrhythmias.
Limitations
Not all circumferential strain data were analysable,
which may potentially have introduced a selection bias
of the results. Also, baseline diastolic blood pressure
was significantly lower in carriers, which may be related
to the selection of carriers without LV hypertrophy.
S t u d yn u m b e r sa r el i m i t e d ,w h i c hm a yh a v ec a u s e d
non-significant results due to insufficient power. Also,
we only evaluated 2 mutations. Yet, these mutations in
these genes account for approximately 25% of the total
HCM population in the Netherlands, and about 20% of
HCM patients worldwide [21]. The slice positions of the
short axis SSFP cines did largely overlap the slice posi-
tions of the tagging slices, though did not completely
correlate. Although unlikely, this methodological limita-
tion may have affected the results. In this study, we
evaluated only the accuracy of deformation in the cir-
cumferential direction in identifying carriers. The accu-
racy of deformation in radial and/or longitudinal
direction for this purpose remains to be elucidated.
Conclusions
HCM mutation carriership is an independent determi-
nant of reduced peak SCS and peak DCSR when LV
wall thickness is within normal limits, and is associated
with increased LA volumes and SL ratio. Using SL ratio
and peak DCSR has a high accuracy to identify carriers.
However, since carriers also display structural abnormal-
ities and focal LGE, we advocate to also evaluate mor-
phology and presence of LGE when screening for
carriers.
Additional file 1: Appendix A. segmental data of carriers and controls
Click here for file
[http://www.biomedcentral.com/content/supplementary/1532-429X-12-
13-S1.DOC]
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